News Announcement

Thyrocare Technologies: Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of The Final Dividend If Any For The Financial Year 2024-25.

15-Apr-2025 Download PDF Thyrocare Tech

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 and to recommend the final dividend if any for the financial year 2024-25.